NCT02504320View on ClinicalTrials.gov

Phase 1, Febuxostat XR Relative Bioavailability Study

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Febuxostat XR 80 mg Capsule F1

Febuxostat extended-release (XR) capsules formulation 1

DRUG

Febuxostat XR 80 mg Capsule F2

Febuxostat XR capsules formulation 2

DRUG

Febuxostat XR 80 mg Capsule F3

Febuxostat XR capsules formulation 3

DRUG

Febuxostat XR 80 mg Capsule F4

Febuxostat XR capsules formulation 4

Trial Locations (1)

78744

Austin

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY